Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 May;8(5):568-73.

An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa

Affiliations
  • PMID: 15137532

An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa

J Lin et al. Int J Tuberc Lung Dis. 2004 May.

Abstract

Objective: To obtain a profile of tuberculosis (TB) cases caused by Mycobacterium tuberculosis in northern KwaZulu Natal (KZN) for 2001.

Method: The demographic and drug resistance characteristics were determined. A total of 251 smear and culture confirmed cases was obtained and the resistance of three major anti-tuberculosis drugs was tested using the proportion method.

Results: The patients were mainly from Ngwelezane (57.8%), Stanger (23.5%) and Manguzi (18.7%); 59.0% were male; 54.2% of the isolates were obtained from new TB patients. The mean age of the TB patients was 29.6 years, with the maximum notification age range at 25-34 years. A high prevalence of drug-resistant and multiresistant TB was observed in this region. At least 55% of previously treated and 19% of new cases from all areas were resistant to at least one of the drugs tested. New patients from Ngwelezane and Manguzi area had a high prevalence of any rifampicin resistance (11.0%) and ethambutol resistance (3.9%), respectively.

Conclusion: Our results indicate that the TB epidemic in northern KZN, especially in Ngwelezane, is severe. An infrastructure to educate stakeholders about the need to ensure consistency in treatment is needed.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources